MedCap AB (publ) (STO:MCAP)
Sweden
· Delayed Price · Currency is SEK 654.00
-10.00 (-1.51%)
Aug 14, 2025, 5:29 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Medtech Revenue (Pre-Q3 2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Revenue (Pre-Q3 2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Pharma | 431.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Pharma Growth | -12.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 500.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Assistive Tech | 767.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Assistive Tech Growth | 24.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Revenue (Post-Q2 2023 Reporting) | 607.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Revenue (Post-Q2 2023 Reporting) Growth | 8.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals | 420.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | -13.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Assistive Technology | 765.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Assistive Technology Growth | 24.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Devices | 322.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Devices Growth | 6.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutrition & Other Food | 251.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutrition & Other Food Growth | 15.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Product | 45.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Product Growth | -3.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 500.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 500.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Other | -31.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Operating Profit (Pre-Q3 2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Operating Profit (Pre-Q3 2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Pharma Operating Profit | 33.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Pharma Operating Profit Growth | -69.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other and Eliminations from Operating Profit | -23.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other and Eliminations from Operating Profit Growth | -4.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | -31.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Assistive Tech Operating Profit | 164.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Assistive Tech Operating Profit Growth | 4.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Operating Profit (Post-Q2 2023 Reporting) | 98.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Operating Profit (Post-Q2 2023 Reporting) Growth | 18.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | -31.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Pharma Adjusted EBITDA | 59.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Pharma Adjusted EBITDA Growth | -52.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other and Eliminations from Adjusted EBITDA | -21.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other and Eliminations from Adjusted EBITDA Growth | 0% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Assistive Tech Adjusted EBITDA | 212.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Assistive Tech Adjusted EBITDA Growth | 11.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Adjusted EBITDA (Post-Q2 2023 Reporting) | 138.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medtech Adjusted EBITDA (Post-Q2 2023 Reporting) Growth | 17.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden | 898.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden Growth | 1.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordic (ex-Sweden) | 448.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordic (ex-Sweden) Growth | 27.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe (ex-Nordic) | 384.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe (ex-Nordic) Growth | 7.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 75.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | 6.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|